interaction records 54 assistance programs 55 0 personal data stored
OmniRx › Tools › Generic competition check › Meclizine Hydrochloride

Generic competition · all medicines · read 12 November 2026

Is there a generic of Meclizine Hydrochloride, and who makes it?

Meclizine Hydrochloride appears in 2 dosage-form groups in the FDA Orange Book as of 12 November 2026, with 10 generic makers listed as marketed across them. 1 group has a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming. This is the Orange Book's listing, not a forecast.

Compiled and checked by Vincent Wesley Couey (ORCID 0009-0005-6869-308X) from the Orange Book data files, downloaded 12 November 2026.

Not medical advice. This page reports what the FDA's Orange Book lists, not what a pharmacy has in stock, what anything costs, or whether a generic is right for you. Ask your pharmacist or prescriber about your own medicine.
Meclizine Hydrochloride2 dosage-form groups in the Orange Book
10generic makers listed
  1. Meclizine Hydrochloride appears in 2 dosage-form groups in the FDA Orange Book as of 12 November 2026, with 10 generic makers listed as marketed across them.
  2. 1 group has a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming.
  3. Patents and exclusivities are shown as listed by the application holder; the Orange Book does not rule on them, and a listed patent is not a statement that a generic is blocked. This says nothing about price, supply or quality.

Tablet, Oral

Four or more generic makers listed

Brand listed as marketed: Antivert. 10 generic makers with 20 generic products listed as marketed; the first generic approval is dated 4 January 1982.

19801985199019952000200520102015202020252030010brand 1982Quagen Pharmaceuticals Llc, first approval 22 May 1989Sandoz Inc, first approval 22 May 1989Jubilant Cadista Pharmaceuticals Inc, first approval 4 June 2010Amneal Pharmaceuticals Of New York Llc, first approval 23 February 2011Epic Pharma Llc, first approval 13 April 2012Aurobindo Pharma Usa Inc, first approval 17 September 2012Heritage Pharmaceuticals Inc Dba Avet Pharmaceuticals Inc, first approval 22 February 2019Zydus Lifesciences Global Fze, first approval 23 June 2020Chartwell Rx Sciences Llc, first approval 11 August 2022data date
generic makers listed as marketed, by first approvallisted patent expiryexclusivity end
Generic maker (applicant)First approvalProducts
Pharmazonenot dated2
Quagen Pharmaceuticals Llc22 May 19891
Sandoz Inc22 May 19891
Jubilant Cadista Pharmaceuticals Inc4 June 20102
Amneal Pharmaceuticals Of New York Llc23 February 20113
Epic Pharma Llc13 April 20122
Aurobindo Pharma Usa Inc17 September 20123
Heritage Pharmaceuticals Inc Dba Avet Pharmaceuticals Inc22 February 20191
Zydus Lifesciences Global Fze23 June 20202
Chartwell Rx Sciences Llc11 August 20223

Patents and exclusivities still listed

No unexpired patent or exclusivity is listed against the marketed brand products in this group.

Tablet, Chewable, Oral

Brand listed, no generic listed as marketed

Brand listed as marketed: Antivert. No generic is listed as marketed (4 generic products listed as discontinued).

Patents and exclusivities still listed

No unexpired patent or exclusivity is listed against the marketed brand products in this group.

US Food and Drug Administration, Orange Book data files, downloaded 12 November 2026. A listed patent is not a ruling that a generic is blocked, and no figure here says anything about price, supply or quality. Check the Orange Book.

Where can you go from this result?

Open it in the check to search another medicine, or see every brand with no generic listed. The FDA explains generic approval in how generic drugs are approved and the FDA generic drug facts, and the Orange Book itself is the FDA Orange Book. To check what is available now, ask your pharmacist, and see the FDA drug shortages page.